rs199475727

Variant summary

Our verdict is Benign. The variant received -9 ACMG points: 0P and 9B. BP4_StrongBS1_SupportingBS2

The NM_001243133.2(NLRP3):​c.-460G>A variant causes a 5 prime UTR change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000462 in 212,248 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).

Frequency

Genomes: 𝑓 0.00044 ( 0 hom., cov: 32)
Exomes 𝑓: 0.00053 ( 0 hom. )

Consequence

NLRP3
NM_001243133.2 5_prime_UTR

Scores

2

Clinical Significance

Uncertain significance criteria provided, single submitter U:3O:1

Conservation

PhyloP100: -0.161

Publications

1 publications found
Variant links:
Genes affected
NLRP3 (HGNC:16400): (NLR family pyrin domain containing 3) This gene encodes a pyrin-like protein containing a pyrin domain, a nucleotide-binding site (NBS) domain, and a leucine-rich repeat (LRR) motif. This protein interacts with the apoptosis-associated speck-like protein PYCARD/ASC, which contains a caspase recruitment domain, and is a member of the NLRP3 inflammasome complex. This complex functions as an upstream activator of NF-kappaB signaling, and it plays a role in the regulation of inflammation, the immune response, and apoptosis. The SARS-CoV 3a protein, a transmembrane pore-forming viroporin, has been shown to activate the NLRP3 inflammasome via the formation of ion channels in macrophages. Mutations in this gene are associated with familial cold autoinflammatory syndrome (FCAS), Muckle-Wells syndrome (MWS), chronic infantile neurological cutaneous and articular (CINCA) syndrome, neonatal-onset multisystem inflammatory disease (NOMID), keratoendotheliitis fugax hereditarian, and deafness, autosomal dominant 34, with or without inflammation. Multiple alternatively spliced transcript variants encoding distinct isoforms have been identified for this gene. Alternative 5' UTR structures are suggested by available data; however, insufficient evidence is available to determine if all of the represented 5' UTR splice patterns are biologically valid. [provided by RefSeq, Aug 2020]
NLRP3 Gene-Disease associations (from GenCC):
  • CINCA syndrome
    Inheritance: AD Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Genomics England PanelApp, Orphanet, Labcorp Genetics (formerly Invitae), G2P
  • cryopyrin-associated periodic syndrome
    Inheritance: AD Classification: DEFINITIVE Submitted by: Illumina
  • familial cold autoinflammatory syndrome
    Inheritance: AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: Orphanet, G2P
  • familial cold autoinflammatory syndrome 1
    Inheritance: AD Classification: STRONG Submitted by: G2P
  • Muckle-Wells syndrome
    Inheritance: AD Classification: SUPPORTIVE Submitted by: Orphanet
  • keratitis fugax hereditaria
    Inheritance: AD Classification: LIMITED Submitted by: Ambry Genetics

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -9 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.95).
BS1
Variant frequency is greater than expected in population nfe. GnomAd4 allele frequency = 0.000435 (66/151636) while in subpopulation NFE AF = 0.00075 (51/67958). AF 95% confidence interval is 0.000586. There are 0 homozygotes in GnomAd4. There are 31 alleles in the male GnomAd4 subpopulation. Median coverage is 32. This position passed quality control check. Existence of Clinvar submissions makes me limit the strength of this signal to Supporting
BS2
High AC in GnomAd4 at 66 AD gene.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001243133.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP3
NM_001243133.2
MANE Select
c.-460G>A
5_prime_UTR
Exon 2 of 10NP_001230062.1A0A7I2R3P8
NLRP3
NM_004895.5
c.-454G>A
5_prime_UTR
Exon 2 of 10NP_004886.3
NLRP3
NM_001127461.3
c.-460G>A
5_prime_UTR
Exon 2 of 9NP_001120933.2A0A7I2PMC6

Ensembl Transcripts

Sel.
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
NLRP3
ENST00000336119.8
TSL:1 MANE Select
c.-460G>A
5_prime_UTR
Exon 2 of 10ENSP00000337383.4A0A7I2R3P8
NLRP3
ENST00000366496.7
TSL:1
c.-460G>A
5_prime_UTR
Exon 1 of 8ENSP00000355452.3A0A7I2PMC6
NLRP3
ENST00000391827.3
TSL:1
c.-460G>A
5_prime_UTR
Exon 2 of 9ENSP00000375703.3A0A7I2PRX0

Frequencies

GnomAD3 genomes
AF:
0.000436
AC:
66
AN:
151522
Hom.:
0
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.000170
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.000263
Gnomad ASJ
AF:
0.00
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000208
Gnomad FIN
AF:
0.0000956
Gnomad MID
AF:
0.00
Gnomad NFE
AF:
0.000750
Gnomad OTH
AF:
0.000964
GnomAD4 exome
AF:
0.000528
AC:
32
AN:
60612
Hom.:
0
Cov.:
0
AF XY:
0.000370
AC XY:
12
AN XY:
32454
show subpopulations
African (AFR)
AF:
0.00
AC:
0
AN:
1290
American (AMR)
AF:
0.00
AC:
0
AN:
3490
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
1266
East Asian (EAS)
AF:
0.00
AC:
0
AN:
2822
South Asian (SAS)
AF:
0.000287
AC:
3
AN:
10448
European-Finnish (FIN)
AF:
0.00110
AC:
3
AN:
2732
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
184
European-Non Finnish (NFE)
AF:
0.000736
AC:
26
AN:
35336
Other (OTH)
AF:
0.00
AC:
0
AN:
3044
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.481
Heterozygous variant carriers
0
1
3
4
6
7
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.000435
AC:
66
AN:
151636
Hom.:
0
Cov.:
32
AF XY:
0.000418
AC XY:
31
AN XY:
74100
show subpopulations
African (AFR)
AF:
0.000170
AC:
7
AN:
41276
American (AMR)
AF:
0.000263
AC:
4
AN:
15224
Ashkenazi Jewish (ASJ)
AF:
0.00
AC:
0
AN:
3466
East Asian (EAS)
AF:
0.00
AC:
0
AN:
5142
South Asian (SAS)
AF:
0.000208
AC:
1
AN:
4812
European-Finnish (FIN)
AF:
0.0000956
AC:
1
AN:
10462
Middle Eastern (MID)
AF:
0.00
AC:
0
AN:
292
European-Non Finnish (NFE)
AF:
0.000750
AC:
51
AN:
67958
Other (OTH)
AF:
0.000954
AC:
2
AN:
2096
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.498
Heterozygous variant carriers
0
5
10
14
19
24
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Variant carriers
0
2
4
6
8
10
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.000635
Hom.:
0
Bravo
AF:
0.000521

ClinVar

ClinVar submissions as Germline
Significance:Uncertain significance
Revision:criteria provided, single submitter
View on ClinVar
Pathogenic
VUS
Benign
Condition
-
1
-
Chronic infantile neurological, cutaneous and articular syndrome (1)
-
1
-
Familial amyloid nephropathy with urticaria AND deafness (1)
-
1
-
Familial cold autoinflammatory syndrome 1 (1)
-
-
-
not provided (1)

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.95
CADD
Benign
7.4
DANN
Benign
0.64
PhyloP100
-0.16
PromoterAI
0.066
Neutral

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs199475727; hg19: chr1-247581643; API